Novartis Aktie
128,14
EUR
-0,16
EUR
-0,12
%
128,16
EUR
-0,82
EUR
-0,64
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novartis Aktie Analyse
| 10.09.19 | Novartis Neutral | UBS AG | |
| 09.09.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 09.09.19 | Novartis Hold | Deutsche Bank AG | |
| 05.09.19 | Novartis Underweight | Barclays Capital | |
| 30.08.19 | Novartis Hold | Deutsche Bank AG | |
| 30.08.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.08.19 | Novartis buy | Jefferies & Company Inc. | |
| 29.08.19 | Novartis buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 28.08.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.07.19 | Novartis Neutral | UBS AG | |
| 29.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.07.19 | Novartis Neutral | UBS AG | |
| 22.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.07.19 | Novartis Hold | HSBC | |
| 19.07.19 | Novartis Neutral | Credit Suisse Group | |
| 19.07.19 | Novartis Hold | Deutsche Bank AG | |
| 19.07.19 | Novartis Underweight | Barclays Capital | |
| 18.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.07.19 | Novartis Neutral | UBS AG | |
| 18.07.19 | Novartis Neutral | UBS AG | |
| 16.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.07.19 | Novartis Hold | Deutsche Bank AG | |
| 05.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.06.19 | Novartis Neutral | UBS AG | |
| 25.06.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.06.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 04.06.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.06.19 | Novartis Neutral | UBS AG | |
| 30.05.19 | Novartis Underweight | Morgan Stanley | |
| 29.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.05.19 | Novartis Neutral | Credit Suisse Group | |
| 28.05.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 27.05.19 | Novartis Neutral | UBS AG | |
| 27.05.19 | Novartis Hold | Deutsche Bank AG | |
| 24.05.19 | Novartis Neutral | UBS AG | |
| 24.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.05.19 | Novartis buy | Kepler Cheuvreux | |
| 17.05.19 | Novartis Neutral | Credit Suisse Group | |
| 16.05.19 | Novartis buy | Jefferies & Company Inc. | |
| 16.05.19 | Novartis Neutral | UBS AG | |
| 09.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.05.19 | Novartis Hold | Deutsche Bank AG | |
| 06.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 25.04.19 | Novartis Neutral | Credit Suisse Group | |
| 25.04.19 | Novartis Hold | Deutsche Bank AG | |
| 25.04.19 | Novartis Hold | HSBC | |
| 25.04.19 | Novartis buy | Jefferies & Company Inc. | |
Werbung
Werbung